Table 1.
Demographic and clinical information for the three groups (hallucinating patients (AVH+), non-hallucinating patients (AVH-), and healthy controls, (Cntrl)).
| AVH+ | AVH- | Cntrl | p (Value) | |
|---|---|---|---|---|
| Sample size (female/male) | 44 (12/32) | 13 (2/11) | 57 (15/42) | 0.72 Fisher’s Exact test |
| Age (mean ± SD) a | 30.1 ± 11.4 | 29.5 ± 9.3 | 30.7 ± 9.9 | 0.92 ANOVA |
| Handedness (A/L/R) b | 2/4/38 | 1/1/11 | 0/6/51 | 0.35 Fisher’s Exact test |
| Scanning after/before the upgrade | 21/23 | 5/8 | 25/32 | 0.86 Fisher’s Exact test |
| Duration of illness | 3.6 ± 4.7 | 2.2 ± 4.4 | - | 0.40 Welch Two Sample t-test |
| Defined Daily Dose (DDD) | 1.02 ± 0.63 | 0.91 ± 0.41 | - | 0.51 Welch Two Sample t-test |
| Smoking/non-smoking | 28/16 | 10/3 | - | 0.51 Fisher’s Exact test |
| Baseline PANSS c positive |
3.0 ± 0.7 | 2.6 ± 0.7 | - | 0.04 Welch Two Sample t-test |
| Baseline PANSS negative |
2.4 ± 0.8 | 2.0 ± 0.7 | - | 0.99 Welch Two Sample t-test |
| Baseline PANSS total |
2.7± 0.6 | 2.3 ± 0.6 | - | 0.03 Welch Two Sample t-test |
a SD—Standard deviation, b A—Ambidextrous, L—Left handed, R—Right handed, c PANSS—Positive and Negative Syndrome Scale.